MBX2329
MBX2329, a potent influenza virus inhibitor, specifically inhibits hemagglutinin (HA) -mediated viral entry with HIV/HA (H5) displaying IC90 of 8.6 μM. MBX2329 inhibits a wide spectrum of influenza A viruses, which includes the 2009 pandemic influenza virus A/H1N1/2009, highly pathogenic avian influenza (HPAI) virus A/H5N1, and oseltamivir-resistant A/H1N1 strains[1].
Product Specifications
CAS Number
1438272-42-4
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Influenza Virus
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/mbx2329.html
Purity
99.90
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
CCC1=CC=CC=C1OCCN2CCCCCC2.[H]Cl
Molecular Formula
C16H26ClNO
Molecular Weight
283.84
Precautions
H302, H315, H319, H335
References & Citations
[1]Basu A, et al. New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion. J Virol. 2014;88 (3) :1447-1460.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
AIRN sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
PE-Linked Polyclonal Antibody to Cluster Of Differentiation 97 (CD97)
PE-Linked Polyclonal Antibody to Cluster Of Differentiation 97 (CD97)
PE-Linked Polyclonal Antibody to Cluster Of Differentiation 97 (CD97)